Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Octanedioate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.63 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.53 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.53 |
| ▸ | FABP3 | P05413 | 7/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28402678 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL6053545 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL30930281 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| Pimelic Acid SCHEMBL6756717 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| Sebacic Acid SCHEMBL306520 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL20577558 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| Azelaic Acid SCHEMBL852024 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL11046980 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8325989 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| Sebacic Acid SCHEMBL29696252 | 1.00 | CA1 (0.63) | CA1HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777600-A | Modified material of lithium ion battery diaphragm and preparation method thereof | 北京博奇电力科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-116808814-A | Efficient composite desulfurization synergist and preparation process thereof | 北京联发迈通科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-112266457-B | Photocuring hydrophilic polyurea nano particle and preparation method and application thereof | 广州市嵩达新材料科技有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-110797208-B | Preparation method and application of electrode material | 南京大学 | 2020-12-22 | — | — | CN | claimed |
| CN-107674234-B | Process for producing polypropylene resin foamed particles | 中国科学院长春应用化学研究所 | 2020-11-03 | — | — | CN | claimed |
| CN-109776961-B | Non-polar polymer negative Poisson's ratio foam material and preparation method thereof | 中国科学院长春应用化学研究所 | 2020-09-01 | — | — | CN | claimed |
| CN-110797208-A | Preparation method and application of electrode material | 南京大学 | 2020-02-14 | — | — | CN | claimed |
| WO-2012143794-A1 | POLYMER STABILIZER SYSTEM FOR POLYMERS CONTAINING HALOGEN | GALATA CHEMICALS GMBH (DE) | 2012-10-26 | — | — | WO | claimed |
| US-4200586-A | Inhibiting the carbon-carbon double bond isomerization of substituted or unsubstituted hydrocarbon compounds | PHILLIPS PETROLEUM COMPANY (US) | 1980-04-29 | — | — | US | claimed |
| EP-4159772-B1 | CPVC PIPE HAVING IMPROVED RESISTANCE TO ENVIRONMENTAL STRESS CRACKING | LUBRIZOL ADVANCED MAT INC (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-3355885-B1 | POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE | ELYSIUM THERAPEUTICS INC (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | NISSHINBO HOLDINGS INC. (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-3861986-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYPEPTIDES AND RELATED METHODS OF DELIVERY | AMRYT ENDO INC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250345438-A1 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY | AMRYT ENDO INC (US) | 2025-11-13 | — | — | US | disclosed |
| WO-1996037202-A1 | DOSAGE FORM COMPRISING OXYBUTYNIN | ALZA CORPORATION (US) | 1996-11-28 | — | — | WO | disclosed |
| EP-0275431-B1 | NOVEL ANTHRACYCLINE DERIVATIVES, A PROCESS FOR PREPARING SAME AND THEIR USE AS MEDICAMENTS | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1992-09-23 | — | — | EP | disclosed |
| EP-0275431-A1 | Novel anthracycline derivatives, a process for preparing same and their use as medicaments | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1988-07-27 | — | — | EP | disclosed |
| US-4412018-A | INTERCALATION COMPOUNDS; ION EXCHANGING; THICKENERS; NONAQUEOUS PAINTS; COATINGS | NL INDUSTRIES, INC. (US) | 1983-10-25 | — | — | US | disclosed |
| US-4212793-A | BY POLYARYLENE SULFIDE RESINS, ADDING CALCIUM HYPOPHOSPHITE, SODIUM TETRABORATE, CITRATE, PHOSPHATE OR PYROPHOSPHATE | PHILLIPS PETROLEUM COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-4200586-A | Inhibiting the carbon-carbon double bond isomerization of substituted or unsubstituted hydrocarbon compounds | PHILLIPS PETROLEUM COMPANY (US) | 1980-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | ALG3, ALG1, HACD3 | CA1 621/4885CA4 629/4885HDAC3 2644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.